FR2400036A1 - Heparines purifiees et leur preparation - Google Patents

Heparines purifiees et leur preparation

Info

Publication number
FR2400036A1
FR2400036A1 FR7823396A FR7823396A FR2400036A1 FR 2400036 A1 FR2400036 A1 FR 2400036A1 FR 7823396 A FR7823396 A FR 7823396A FR 7823396 A FR7823396 A FR 7823396A FR 2400036 A1 FR2400036 A1 FR 2400036A1
Authority
FR
France
Prior art keywords
heparin
aqueous solution
oxalates
purified
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7823396A
Other languages
English (en)
Other versions
FR2400036B1 (fr
Inventor
Jean Goulay
Jean Choay
Jean-Rene Duclos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB33170/77A external-priority patent/GB1602439A/en
Application filed by Choay SA filed Critical Choay SA
Publication of FR2400036A1 publication Critical patent/FR2400036A1/fr
Application granted granted Critical
Publication of FR2400036B1 publication Critical patent/FR2400036B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

Procédé pour purifier l'éparine et en particulier pour éliminer les sels minéraux qu'elle contient, y compris les oxalates, et produits obtenus par ce procédé. A une solution aqueuse de l'héparine à traiter, par exemple une solution du commerce, on ajoute un agent précipitant non-ionique tel qu'un alcool, en quantité réglée de manière à provoquer la précipitation sélective de l'héparine ou du sel d'héparine cependant que les sels minéraux restent dans la solution aqueuse, on recueille l'héparine précipitée et, lorsque c'est nécessaire, on répète l'opération sur une nouvelle solution aqueuse de l'héparine récupérée jusqu'à ce que la concentration en oxalates de l'héparine finale soit inférieure à 30 ppm. L'héparine purifiée conformément à l'invention ne donne pas lieu aux précipités et troubles constatés antérieurement dans les préparations pharmaceutiques de ce médicament.
FR7823396A 1977-08-08 1978-08-08 Heparines purifiees et leur preparation Granted FR2400036A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB33170/77A GB1602439A (en) 1977-08-08 1977-08-08 Purified heparin
GB5204777 1977-12-14

Publications (2)

Publication Number Publication Date
FR2400036A1 true FR2400036A1 (fr) 1979-03-09
FR2400036B1 FR2400036B1 (fr) 1980-09-19

Family

ID=26261753

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7823396A Granted FR2400036A1 (fr) 1977-08-08 1978-08-08 Heparines purifiees et leur preparation

Country Status (14)

Country Link
US (1) US4652555A (fr)
JP (1) JPS5446809A (fr)
AT (1) AT371713B (fr)
AU (1) AU529432B2 (fr)
CA (1) CA1105453A (fr)
CH (1) CH636888A5 (fr)
DE (1) DE2834702A1 (fr)
DK (1) DK350078A (fr)
ES (1) ES472430A1 (fr)
FR (1) FR2400036A1 (fr)
IE (1) IE47169B1 (fr)
IT (1) IT1192564B (fr)
NL (1) NL7808292A (fr)
SE (1) SE447872B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461719A2 (fr) * 1979-07-20 1981-02-06 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059321T3 (es) * 1986-05-16 1994-11-16 Italfarmaco Spa Heparinas, fracciones y fragmentos de heparinas libres de edta, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR243204A1 (es) * 1986-11-21 1993-07-30 Ajorca Sa Un metodo para la depolimerizacion quimica de polisacaridos.
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
USRE38743E1 (en) 1990-06-26 2005-06-14 Aventis Pharma S.A. Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
JP2001231595A (ja) * 1999-12-15 2001-08-28 Fuaruko Bio Syst:Kk 特異的破骨細胞由来酸性ホスファターゼの測定方法
JP4828795B2 (ja) * 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2283045A1 (fr) * 2008-05-20 2011-02-16 Crystal Clear Partnership Séparation de polysaccharides par un gradient de densité de charge
ES2340902B1 (es) 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
CN102791742B (zh) * 2010-01-19 2014-12-24 动量制药公司 评价肝素制剂
CA3020369C (fr) 2010-09-14 2019-11-26 University Of Miyazaki Heparine de purete elevee et procede de production associe
WO2012115952A1 (fr) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Évaluation de préparations d'héparine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2225406A1 (en) * 1973-04-13 1974-11-08 Choay Sa Sodium-free heparin salts - by cation exchange of sodium salts, anticoagulants without side-effects

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135660A (en) * 1956-11-09 1964-06-02 Riker Laboratories Inc Method for purifying sulfated carbohydrates with oxidizing agents
US3482014A (en) * 1966-06-29 1969-12-02 Canada Packers Ltd Orally active heparin and method for making and using same
CA1042001A (fr) * 1973-04-13 1978-11-07 Choay S.A. Sels d'heparine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2225406A1 (en) * 1973-04-13 1974-11-08 Choay Sa Sodium-free heparin salts - by cation exchange of sodium salts, anticoagulants without side-effects

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2461719A2 (fr) * 1979-07-20 1981-02-06 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir

Also Published As

Publication number Publication date
AT371713B (de) 1983-07-25
AU3874878A (en) 1980-02-14
IE781616L (en) 1979-02-08
ATA577078A (de) 1982-12-15
DE2834702C2 (fr) 1988-11-10
DK350078A (da) 1979-02-09
SE447872B (sv) 1986-12-22
NL7808292A (nl) 1979-02-12
IE47169B1 (en) 1984-01-11
US4652555A (en) 1987-03-24
JPS6129327B2 (fr) 1986-07-05
AU529432B2 (en) 1983-06-09
JPS5446809A (en) 1979-04-13
DE2834702A1 (de) 1979-02-22
SE7808487L (sv) 1979-02-09
CH636888A5 (fr) 1983-06-30
IT7826580A0 (it) 1978-08-08
IT1192564B (it) 1988-04-20
CA1105453A (fr) 1981-07-21
ES472430A1 (es) 1979-03-16
FR2400036B1 (fr) 1980-09-19

Similar Documents

Publication Publication Date Title
FR2400036A1 (fr) Heparines purifiees et leur preparation
FI950957A0 (fi) Menetelmä ksyloosin kiteyttämiseksi vesiliuoksista
JPH0261482B2 (fr)
FR2405259A1 (fr) Procede de preparation et de purification du facteur citrovorum par precipitation des impuretes de ce facteur et nouveau produit ainsi obtenu
NO950965L (no) Fremgangsmåte til rensing av avlöpsvann, samt gjenvinning av urenheter fra slikt vann
CA2235712A1 (fr) Procede de dessalement, de demineralisation de solutions contenant des acides et/ou des sels metalliques
EP0162426A2 (fr) Procédé d'obtention d'une préparation de facteur XIII et son utilisation
JP4104576B2 (ja) ジアセチルレインの精製方法
US2385903A (en) Water treatment
SE8100218L (sv) Forfarande for utvinning av anvendbara produkter ur avfallsprodukter fran aluminiumfluoridframstellning
GB1479880A (en) Process for the purification of aqueous solutions of glycerol
DE1492229A1 (de) Verfahren zur Gewinnung von kristallinem Insulin
FR2379988A1 (fr) Procede perfectionne pour la filtration de produits d'hydrolyse de sangs d'animaux
SE7906137L (sv) Rening av faktor viii
JP2838897B2 (ja) ロダン塩の回収方法
SU1639042A1 (ru) Способ очистки отработанного смазочного масла
JPS60133887A (ja) エラスタ−ゼの製法
US2068149A (en) Process of purifying and fractionating mahogany sulphonates and products thereof
US4418016A (en) Method for recovering omega-amino-dodecanoic acid from crystallization mother liquors
SU508042A1 (ru) Способ очистки четыреххлорногоТиТАНА
SU789392A1 (ru) Способ переработки фторсодержащих отходов алюминиевого производства
SU960161A1 (ru) Способ очистки соли
DE3838352A1 (de) Verfahren zur reinigung eines polysaccharidmediums zur erhoehung von dessen filtrierbarkeit und verwendung des gereinigten mediums zur durch hilfsmittel unterstuetzten erdoelfoerderung
DE689215C (de) Verfahren zum Entarsenieren von Roestgasen mittels Schwefelsaeure und deren Reinigung
DE909936C (de) Verfahren zur Gewinnung von Wirkstoffen aus Blueten von Arnica montana

Legal Events

Date Code Title Description
ST Notification of lapse